Safety of 100 µg venom immunotherapy rush protocols in children compared to adults

Safety of 100 µg venom immunotherapy rush protocols in children compared to adults

Abstract Background There is a paucity of studies examining the safety of venom immunotherapy (VIT) in children. We aimed to assess the incidence of anaphylactic side effects during rush VIT in a cohort of pediatric patients and adult controls. Methods 72 consecutive cycles of VIT-buildup in 71 chil...

Full description

Bibliographic Details
Main Authors: Johanna Stoevesandt, Christine Hosp, Andreas Kerstan, Axel Trautmann
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Anaphylaxis
Bee
Buildup phase
Hymenoptera
Pediatric
Risk factor
Online Access:http://link.springer.com/article/10.1186/s13223-017-0204-y

Internet

http://link.springer.com/article/10.1186/s13223-017-0204-y

Similar Items